Why the study?
Does nifedipine slow-release monotherapy reduce blood pressure in elderly patients with essential mild to moderate hypertension?
Does nifedipine slow-release monotherapy reduce blood pressure in elderly patients with essential mild to moderate hypertension?
Nifedipine slow-release monotherapy effectively reduces blood pressure in elderly patients with mild to moderate hypertension, though it may cause severe leg edema in a subset of patients.
Answers are grounded in this paper and cite their sources.
May support nifedipine slow-release for BP control in elderly hypertension; leaves open long-term safety and randomized confirmation.
A single-blind, placebo-controlled study was carried out to evaluate the suitability of slow-release nifedipine as antihypertensive monotherapy for the elderly. After a wash-out period, nifedipine slow-release tablets (20 mg twice daily) followed by matching placebo were administered, each for 4 weeks, to 23 patients over 60 years of age with essential mild to moderate hypertension. Nifedipine significantly reduced the systolic and diastolic blood pressure, and increased the pulse rate in both supine and upright positions. The pre-treatment supine systolic blood pressure proved the best single predictor of the blood pressure decreases in both positions. The decrease in mean arterial blood pressure correlated significantly with the nifedipine plasma concentration. Significant biochemical changes were observed with nifedipine, namely increased serum K+ level and decreased levels of serum Na+, cholesterol and triglycerides. Side-effects in general were mild and transient; nevertheless, 3 patients dropped out because of severe leg oedema.
No takes yet. Share an insight, caveat, or question.
Schnapp et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: